Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Alvotech (ALVOW) Current Deferred Revenue (2020 - 2025)

Historic Current Deferred Revenue for Alvotech (ALVOW) over the last 6 years, with Q3 2025 value amounting to $80.7 million.

  • Alvotech's Current Deferred Revenue fell 559.17% to $80.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.7 million, marking a year-over-year decrease of 559.17%. This contributed to the annual value of $80.7 million for FY2024, which is 1018.28% up from last year.
  • As of Q3 2025, Alvotech's Current Deferred Revenue stood at $80.7 million, which was down 559.17% from $60.3 million recorded in Q2 2025.
  • In the past 5 years, Alvotech's Current Deferred Revenue ranged from a high of $90.1 million in Q2 2024 and a low of $32.3 million during Q2 2022
  • Moreover, its 5-year median value for Current Deferred Revenue was $73.3 million (2023), whereas its average is $67.2 million.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first skyrocketed by 8243.63% in 2023, then plummeted by 3305.26% in 2025.
  • Alvotech's Current Deferred Revenue (Quarter) stood at $44.8 million in 2021, then grew by 27.15% to $57.0 million in 2022, then rose by 28.49% to $73.3 million in 2023, then increased by 10.18% to $80.7 million in 2024, then changed by 0.0% to $80.7 million in 2025.
  • Its Current Deferred Revenue stands at $80.7 million for Q3 2025, versus $60.3 million for Q2 2025 and $87.0 million for Q1 2025.